Status:
WITHDRAWN
Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
Lead Sponsor:
Marquette General Health System
Collaborating Sponsors:
Upper Michigan Brain Tumor Center
Conditions:
Glioma
Meningioma
Eligibility:
All Genders
Brief Summary
Objectives: This study is looking at the level of vascular endothelial growth factor (VEGF) circulating in the blood stream of patients diagnosed with either a meningioma or a glioma. The questions th...
Eligibility Criteria
Inclusion
- any patient presenting with glioma or meningioma
Exclusion
- a different type of brain tumor
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00985036
Start Date
September 1 2009
End Date
January 1 2012
Last Update
April 24 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marquette General Hospital
Marquette, Michigan, United States, 49855